FDA recently granted Pentax approval to market a duodenoscope with fewer parts that need to be cleaned, according to an article on the Advisory Board website.
According to FDA, as many as 350 patients at 41 medical facilities across the globe were infected by or exposed to contaminated gastrointestinal scopes between 2010 and 2015.
Contaminated scopes had killed at least 35 patients in the United States from 2013 to January 2017.
FDA in 2013 started to collaborate with duodenoscope manufacturers Fujifilm, Olympus, and Pentax to address contamination risks.
Spaces That Support: Patient-Centered Design for Modern Reproductive Health
Modernization of Buildings Require Collaboration Across All Disciplines
Children's Health Announces Plans for RedBird Specialty Center in Texas
How Can Healthcare Facilities Use Efficiency to Drive Climate and Health Goals?
El Camino Health Rehabilitation Hospital Officially Tops Out